63 Biggest Movers From Friday



  • ERYTECH Pharma S.A. ERYP shares surged 55% to close at $6.37 on Friday after the company said the FDA has granted its eryaspase fast track designation for the treatment of acute lymphocytic leukemia patients who have developed hypersensitivity reactions to E. coli-derived pegylated asparaginase.
  • Allied Healthcare Products, Inc. AHPI climbed 38.9% to settle at $8.25 amid earlier comments from former FDA Commissioner he 'wouldn't be surprised' if 1m/day are being infected with delta variant.
  • MaxCyte, Inc. MXCT surged 30.8% to settle at $17.00. The company priced a $176 million IPO at $13 a piece, on the higher end of an $11.50 to $13.50 range.
  • Marin Software Incorporated MRIN gained 28.2% to close at $8.28. After the closing bell on Friday, Marin Software reported an adjusted loss of $0.21 per share for the second quarter, versus a year-ago loss of $0.36 per share.
  • Atlassian Corporation Plc TEAM shares climbed 21.9% to close at $325.12 after the company reported better-than-expected Q4 results and issued strong Q1 guidance.
  • Rallybio Corporation RLYB shares gained 20.6% to close at $17.00. Rallybio priced its IPO at $13 per share.
  • Sentage Holdings Inc. SNTG rose 17.3% to settle at $5.50.
  • Immuneering Corporation IMRX gained 17.3% to close at $17.59. The company priced its IPO at $15 a share.
  • Silicon Motion Technology Corporation SIMO rose 16.6% to settle at $74.99 after the company reported better-than-expected Q2 EPS and sales results. The company also reported guidance figures.
  • Alpha Pro Tech, Ltd. APT gained 15.4% to close at $12.01 along with other masks, PPE and respiratory product makers after CDC documents warned the COVID-19 Delta variant appears to be as contagious as chickenpox.
  • Orbsat Corp. OSAT gained 14.8% to settle at $7.74.
  • Brainstorm Cell Therapeutics Inc. BCLI surged 14.5% to close at $4.03.
  • Power Integrations, Inc. POWI jumped 14.1% to settle at $96.99 following upbeat Q2 results.
  • Veracyte, Inc. VCYT gained 13.6% to settle at $44.56 after the company reported better-than-expected Q2 results and raised FY21 sales guidance.
  • GH Research PLC GHRS rose 13.5% to close at $19.70.
  • Mitek Systems, Inc. MITK climbed 13.3% to settle at $22.11 following Q3 results.
  • One Stop Systems, Inc. OSS gained 13.2% to close at $5.99. One Stop Systems is expected to report Q2 earnings on August 12.
  • Bit Digital, Inc. BTBT rose 13.1% to settle at $9.00.
  • DexCom, Inc. DXCM gained 13% to close at $515.51 as second-quarter results easily topped the consensus forecast.
  • Silk Road Medical, Inc SILK jumped 12.9% to settle at $50.18 following Q2 results.
  • Capri Holdings Limited CPRI gained 12.5% to close at $56.31 after the company reported better-than-expected Q1 results. The company also raised its FY22 EPS and sales guidance.
  • Bel Fuse Inc. BELFB jumped 12.4% to close at $13.64 after reporting Q2 results.
  • Hawkins, Inc. HWKN rose 12.4% to settle at $36.31 folloiwng strong quarterly results.
  • Li Auto Inc. LI gained 12% to $34.33.
  • Ucommune International LtdUK shares climbed 11.8% to close at $1.23 as the company signed a cooperation agreement for asset-light project at the Beijing Asia Financial Center.
  • Research Frontiers Incorporated REFR gained 11.8% to close at $2.55.
  • Misonix, Inc. MSON rose 11.3% to close at $26.54. Bioventus Incannounced an agreement to buy Misonix in a cash-and-stock deal.
  • KLA Corporation KLAC gained 9% to close at $348.16 after the company reported better-than-expected Q4 results. The company also issued Q1 EPS and sales guidance with a midpoint above analyst estimates.
  • Viant Technology Inc. DSP rose 8.2% to close at $17.29 after B of A Securities upgraded the stock from Neutral to Buy and announced a $30 price target.
  • First High-School Education Group Co., Ltd. FHS rose 7.5% to close at $3.71.


Check out these big penny stock gainers and losers


  • Cassava Sciences, Inc. SAVA shares dipped 32.7% to settle at $69.53 amid investor and analyst reaction to the company's recent biomarker data from an open-label study of simufilam, its investigational drug for the treatment of Alzheimer's disease.
  • Icosavax, Inc. ICVX shares tumbled 29% to close at $24.85 on Friday. Icosavax priced an upsized $182 million IPO, which had initially penciled in a $100 million raise.
  • Atossa Therapeutics, Inc. ATOS fell 23.3% to settle at $2.99. Atossa Therapeutics, earlier during the month, said it received regulatory approval to open clinical study of AT-H201 in Australia.
  • Xenetic Biosciences, Inc. XBIO dropped 23.2% to settle at $4.07 after jumping 65% on Thursday. Xenetic Biosciences recently reported closing of $12.5 million private placement priced at a premium to market.
  • Translate Bio, Inc. TBIO dropped 22.4% to close at $27.64.
  • Annovis Bio, Inc. ANVS fell 20.9% to settle at $34.43. Weakness was attributed to sympathy with peer Cassava, which has fallen following recent Alzheimer's data.
  • Pinterest, Inc. PINS dropped 18.2% to close at $58.90. Pinterest reported upbeat earnings and sales results for its second quarter on Thursday. However, the company reported weaker-than-expected growth in monthly active users and issued bearish revenue forecast for the third quarter. JP Morgan and Evercore ISI Group downgraded the stock.
  • Zynex, Inc. ZYXI dipped 17% to close at $13.89 after the company reported worse-than-expected Q2 sales results.
  • PainReform Ltd. PRFX fell 16.7% to settle at $2.88.
  • Intec Pharma Ltd NTEC shares dropped 16.7% to close at $11.29 on Friday after jumping 48% on Thursday. Intec Pharma recently reported a $30 million private placement.
  • Credicorp Ltd. BAP fell 16.4% to settle at $100.96. Credicorp is expected to report Q2 earnings on Thursday August 12, 2021.
  • 1stdibs.Com, Inc. DIBS dropped 15.1% to close at $16.25.
  • Newegg Commerce, Inc. NEGG fell 14.7% to settle at $17.20.
  • Mammoth Energy Services, Inc. TUSK dropped 14.1% to close at $3.66 following downbeat Q2 results.
  • IGM Biosciences, Inc. IGMS fell 13.7% to close at $68.01. IGM Biosciences appointed Chris H. Takimoto, M.D., Ph.D., F.A.C.P., to the role of Chief Medical Officer.
  • Zendesk, Inc. ZEN fell 13.3% to close at $130.53 after the company reported worse-than-expected Q2 results.
  • EyeGate Pharmaceuticals, Inc. EYEG dropped 13.1% to close at $2.52.
  • MediaCo Holding Inc. MDIA dipped 13.1% to settle at $5.91.
  • Tricida, Inc. TCDA fell 12.8% to close at $3.56. Tricida is scheduled to release Q2 results on August 9.
  • Pliant Therapeutics, Inc. PLRX fell 12.7% to settle at $20.20.
  • GT Biopharma, Inc. GTBP dropped 12.3% to close at $9.95. The company recently reported $16 million in warrant exercise proceeds.
  • Waterdrop Inc. WDH fell 12.1% to close at $4.22.
  • Iterum Therapeutics plc ITRM shares declined 10.3% to close at $0.7789 after jumping over 16% on Thursday. The company recently received a Complete Response Letter from the Food and Drug Administration requesting at least 1 additional trial.
  • Upwork Inc. UPWK fell 10% to close at $51.79 after the company reported Q2 earnings results and issued Q3 and FY21 guidance.
  • Zedge, Inc. ZDGE dropped 10% to settle at $15.36.
  • Dole PLC DOLE shares declined 9.4% to close at $14.50 after pricing its IPO at $16 a share.
  • Acer Therapeutics Inc. ACER fell 8.6% to settle at $2.56 after jumping over 15% on Thursday.
  • US Ecology, Inc. ECOL fell 8.3% to close at $35.00 after the company reported a wider quarterly loss.
  • MoneyGram International, Inc. MGI fell 8.3% to close at $10.34 following Q2 results.
  • Amazon.com, Inc. AMZN fell 7.6% to settle at $3,327.59. Amazon.com reported better-than-expected earnings for its second quarter, while sales missed expectations. The company also issued weak sales forecast for the current quarter.
  • Skyworks Solutions, Inc. SWKS shares fell 6.2% to close at $184.51 after the company reported Q3 earnings results and issued Q4 guidance.
  • ATI Physical Therapy, Inc. ATIP fell 6.1% to close at $3.41.
  • Plantronics, Inc. POLY fell 4.7% to close at $31.19 after the company issued Q2 guidance below estimates.

Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasMovers From YesterdayTop Gainers